Literature DB >> 16426238

Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.

K Bogunia-Kubik1, G Mazur, I Urbanowicz, T Wróbel, K Kuliczkowski, M Woźniak, A Lange.   

Abstract

B-cell chronic lymphocytic leukaemia (B-CLL) is a lymphoproliferative disorder characterized by clonal expansion of B lymphocytes. The present study aimed to determine whether there is an association between the polymorphic features located within the promoter/enhancer region of tumour necrosis factor-alpha (TNFA) gene and susceptibility to B-CLL. TNFA (-308 G/A) promoter single nucleotide polymorphism (SNP) was determined by polymerase chain reaction with sequence-specific primers (PCR-SSP) using commercial oligonucleotides. No significant association was found between the distribution of TNFA alleles and B-CLL in Polish patients with B-CLL. Our single centre results were compared with other literature data and combined in a cumulative analysis employing the Mantel-Haenszel method. Among 183 B-CLL patients, 47 (26%) were carrying TNFA*2 allele and this allele was present in 98 out of 348 controls (28%). Also, the results of the Mantel-Haenszel test did not show a significant correlation [Mantel-Haenszel estimate of approximate relative risk (RMH) = 0.86, P = 0.294]. These results suggest that TNFA (-308) alleles are not involved in the predisposition to the development of B-CLL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426238     DOI: 10.1111/j.1744-313X.2005.00553.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  7 in total

1.  IFN gamma gene polymorphism may contribute to the susceptibility to CLL.

Authors:  Iwona Urbanowicz; Grzegorz Mazur; Jolanta Stacherzak-Pawlik; Katarzyna Bogunia-Kubik; Tomasz Wróbel; Mieczysław Woźniak; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2009-09-15       Impact factor: 3.201

Review 2.  Inherited predisposition to chronic lymphocytic leukemia.

Authors:  Jennifer R Brown
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

3.  Current Trends in Management of Oral Mucositis in Cancer Treatment

Authors:  Abhishek Shankar; Shubham Roy; Menal Bhandari; G K Rath; Aalekhya Sharma Biswas; Ravi Kanodia; Narayan Adhikari; Rashika Sachan
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

4.  Association of TNF-α rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia.

Authors:  Ezeldine K Abdalhabib; Abdulrahman Algarni; Muhammad Saboor; Fehaid Alanazi; Ibrahim K Ibrahim; Ayman H Alfeel; Abdullah M Alanazi; Abdulmajeed M Alanazi; Abdulaziz M Alruwaili; Muath H Alanazi; Nahla A Alshaikh
Journal:  Genes (Basel)       Date:  2022-07-13       Impact factor: 4.141

5.  The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.

Authors:  Yong-Qiao He; Jin-Hong Zhu; Shao-Yi Huang; Zhuo Cui; Jing He; Wei-Hua Jia
Journal:  Tumour Biol       Date:  2014-09-10

6.  Influence of IL10 (G1082A) and TNFα (G308A) Polymorphisms on the Survival of Pediatric Patients with ALL.

Authors:  Dayse Maria Vasconcelos de Deus; Karina Araújo Lugo; Maria Tereza Cartaxo Muniz
Journal:  Leuk Res Treatment       Date:  2012-10-02

Review 7.  Oral Mucositis Induced By Anticancer Therapies.

Authors:  Sali Al-Ansari; Judith A E M Zecha; Andrei Barasch; Jan de Lange; Fred R Rozema; Judith E Raber-Durlacher
Journal:  Curr Oral Health Rep       Date:  2015-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.